Adhesive Pili in UTI pathogenesis and drug development

Caitlin N. Spaulding, Scott J. Hultgren

Research output: Contribution to journalReview articlepeer-review

45 Scopus citations


Urinary tract infections (UTIs) are one of the most common bacterial infections, affecting 150 million people each year worldwide. High recurrence rates and increasing antimicrobial resistance among uropathogens are making it imperative to develop alternative strategies for the treatment and prevention of this common infection. In this Review, we discuss how understanding the: (i) molecular and biophysical basis of host-pathogen interactions; (ii) consequences of the molecular cross-talk at the host pathogen interface in terms of disease progression; and (iii) pathophysiology of UTIs is leading to efforts to translate this knowledge into novel therapeutics to treat and prevent these infections.

Original languageEnglish
Article number30
Issue number1
StatePublished - Mar 15 2016


  • Antibiotic-resistance
  • Chaperone-usher pathway (CUP) pili
  • Enterococcus
  • Pili
  • RUTI
  • UPEC
  • UTI
  • Vaccine

Fingerprint Dive into the research topics of 'Adhesive Pili in UTI pathogenesis and drug development'. Together they form a unique fingerprint.

Cite this